Transplant Institute | Medicine | MedStar Health

Transplant medicine that changes lives

MedStar Georgetown Transplant Institute offers the complete spectrum of care from evaluation and medical management to cutting-edge surgery and transplant procedures. We provide hope and life-restoring treatments for patients with end-stage organ failure.

The Institute is one of the highest volume organ transplant programs in the country and offers the expertise of some of the foremost US transplant specialists. We have performed more than 8,500 liver, kidney, pancreas, small bowel, and multi-organ transplants. And our volumes speak volumes. For all organs, our one-year adult and pediatric survival rates are among the best in the country.

To learn more, please call 202-444-3700.

One of the highest volume transplant programs in the country

  • 8,500+ transplants (liver, kidney, pancreas, small bowel, and multi-organ).

  • 340 kidney transplants in 2020.

  • 120+ liver transplants a year.

  • High volumes, superior outcomes (United States).

  • The region’s only 5-tier liver transplant program for 1-year organ survival.

  • Among top 3 programs by volume for pediatric liver transplants.

  • Among the top 5% of the highest volume centers for kidney transplants.

  • One of the largest national paired kidney exchange sharing program.

  • Second largest national program by volume for pancreas transplants.

  • Among the top 2 intestinal transplant programs by volume with patients from 15 countries.

  • Among the top 10 programs by volume for all abdominal transplants.


A team of transplant surgeons from MedStar Georgetown University Hospital pose for a group photo in the operating room.

Our providers

Our multidisciplinary team of nationally known surgeons and medical specialists helps patients and their loved ones through the transplant process.

Refer a patient

Provider and Dialysis Social Workers

Refer a patient to our program

Research and education

A female scientist works in a clinical laboratory and looks at cells on a computer monitor.


The Center for Translational Transplant Medicine has launched approximately 100 clinical trials since 2013. Research topics include immunity modulation, inflammation, cellular reprogramming, tolerance induction, and other potential paths to improve graft survival and reduce infection and rejection, particularly for complex small bowel transplantations.

See More